Literature DB >> 35755233

Clinical Problem Solving: A 56-Year-Old Woman With Right Facial Weakness, Numbness, and Diplopia.

Kun-Wei Song1,2,3, Joshua Budhu1,2,3, Catherine Isroff1,2, Stephanie Siegmund4, L Nicolas Gonzalez Castro1,3.   

Abstract

We discuss a case of a middle-aged woman with a history of urothelial carcinoma, who presented with subacute progression of double vision, right facial numbness, and back pain. Her MRI brain and spine demonstrated multifocal enhancing lesions at the skull base and throughout the spine. Since her initial serum and cerebrospinal fluid (CSF) studies were unrevealing, she underwent a biopsy of her skull base lesion, which was initially concerning for infection. However, her symptoms worsened despite appropriate antibiotic therapy, necessitating a spinal root biopsy that was consistent with leptomeningeal urothelial carcinoma. Her case illustrates the challenge of accurately diagnosing isolated leptomeningeal metastatic disease, which can be difficult to diagnose from CSF analysis and often requires multiple lumbar punctures to improve sensitivity. While genitourinary cancers rarely metastasize to the CNS, clinicians should retain high suspicion for neoplastic etiologies of leptomeningeal disease in patients with a history of cancer and new neurologic deficits.
© The Author(s) 2022.

Entities:  

Keywords:  brain neoplasms; clinical specialty; leptomeningeal neoplasms; nervous system neoplasms; neuro-oncology

Year:  2022        PMID: 35755233      PMCID: PMC9214925          DOI: 10.1177/19418744221074456

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  9 in total

1.  Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.

Authors:  C N Sternberg; A Yagoda; H I Scher; R C Watson; N Geller; H W Herr; M J Morse; P C Sogani; E D Vaughan; N Bander
Journal:  Cancer       Date:  1989-12-15       Impact factor: 6.860

2.  Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results.

Authors:  M J Glantz; B F Cole; L K Glantz; J Cobb; P Mills; A Lekos; B C Walters; L D Recht
Journal:  Cancer       Date:  1998-02-15       Impact factor: 6.860

Review 3.  Leptomeningeal metastasis from systemic cancer.

Authors:  Jennifer L Clarke
Journal:  Continuum (Minneap Minn)       Date:  2012-04

4.  Leptomeningeal metastases in the MRI era.

Authors:  J L Clarke; H R Perez; L M Jacks; K S Panageas; L M Deangelis
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

Review 5.  Leptomeningeal metastasis from systemic cancer: Review and update on management.

Authors:  Nancy Wang; Mia S Bertalan; Priscilla K Brastianos
Journal:  Cancer       Date:  2017-11-22       Impact factor: 6.860

6.  Symptomatic brain metastases from small-cell carcinoma of the urinary bladder: The Netherlands Cancer Institute experience and literature review.

Authors:  A Bex; G S Sonke; F J Pos; D Brandsma; J M Kerst; S Horenblas
Journal:  Ann Oncol       Date:  2010-04-28       Impact factor: 32.976

7.  Leptomeningeal metastases from genitourinary cancer: the University of Texas MD Anderson Cancer Center experience.

Authors:  Shlomit Yust-Katz; Samuel Mathis; Morris D Groves
Journal:  Med Oncol       Date:  2013-01-05       Impact factor: 3.064

8.  A case of brain and leptomeningeal metastases from urothelial carcinoma of the bladder.

Authors:  S Erhamamcı; M Reyhan; N Altinkaya
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2014-07-17       Impact factor: 1.359

9.  Brain metastases from bladder carcinoma: presentation, treatment and survival.

Authors:  Ashraf S Mahmoud-Ahmed; John H Suh; Patrick A Kupelian; Eric A Klein; David M Peereboom; Robert Dreicer; Gene H Barnett
Journal:  J Urol       Date:  2002-06       Impact factor: 7.450

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.